Murray Levy

Murray Levy has a diverse background in finance, with experience ranging from financial planning and analysis to financial analyst roles. Their most recent position is with EmVenio Research, where they serve as the Director of Financial Planning and Analysis starting in January 2023. Prior to that, from February 2021 to January 2023, they worked as an Associate Director of Finance at MEI Pharma. Before that, Murray was a Senior Financial Analyst at Custopharm, Inc. from January 2018 to February 2021 and at Teva Pharmaceuticals from February 2017 to December 2017. Murray also gained experience as a Project Financial Analyst at PRA Health Sciences from October 2015 to January 2017 and at Acurian from June 2013 to October 2015. Additionally, they worked as a Junior Financial Analyst at Acurian from September 2012 to June 2013. Murray began their finance career at Parkshore Pharmacon as a Finance employee, starting in May 2010 and ending in May 2011.

Murray Levy attended Muhlenberg College from 2008 to 2010, where they pursued a Bachelor of Arts (BA) degree in Economics. Following this, they enrolled at Clemson University from 2010 to 2012 to further their studies in Economics and obtained another Bachelor of Arts (BA) degree.